Drug intelligence / Profile preview

weifuchun + hydrotalcite + l-glutamine + sodium gualenate

Development stage: Unknown
Lead developer: Huadong Medicine
Modality: Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Oral

Overview

This combination therapeutic regimen is widely used in China for the treatment of chronic atrophic gastritis (CAG) and the prevention of gastric cancer. It consists of **Weifuchun**, a traditional Chinese medicine (TCM) capsule developed by Huadong Medicine that contains *Isodon amethystoides*, *Pseudostellaria heterophylla*, and *Citrus aurantium* to improve mucosal blood flow and reverse intestinal metaplasia; **hydrotalcite**, an antacid and mucosal protectant that neutralizes gastric acid and binds bile acids; and a combination of **l-glutamine** and **sodium gualenate** (guaiazulene sodium sulfonate), which promotes mucosal repair by stimulating hexosamine synthesis and providing direct anti-inflammatory effects. The regimen is clinically valued for its ability to alleviate symptoms such as epigastric pain and bloating while promoting the histological recovery of the gastric mucosa.

Brand names: TalcidMarzulene
Other names: Weifuchun + Hydrotalcite + L-Glutamine and Guaiazulene Sodium Sulfonate Granules

Beyond the preview

Go deeper on weifuchun + hydrotalcite + l-glutamine + sodium gualenate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on weifuchun + hydrotalcite + l-glutamine + sodium gualenate.

Explore the full profile